Ovarian cancer stem cells and targeted therapy

被引:75
|
作者
Keyvani, Vahideh [1 ,2 ]
Farshchian, Moein [3 ]
Esmaeili, Seyed-Alireza [4 ,5 ]
Yari, Hadi [6 ]
Moghbeli, Meysam [2 ]
Nezhad, Seyed-Reza Kazemi [2 ]
Abbaszadegan, Mohammad Reza [1 ]
机构
[1] Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Razavi Khorasan, Iran
[2] Shahid Chamran Univ Ahvaz, Dept Biol, Fac Sci, Ahvaz, Iran
[3] Acad Ctr Educ Culture & Res ACECR, Khorasan Razavi Branch, Stem Cell & Regenerat Med Res Grp, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Immunol Res Ctr, Bu Ali Res Inst, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Fac Med, Dept Immunol, Mashhad, Razavi Khorasan, Iran
[6] Natl Inst Genet Engn & Biotechnol, Div Human Genet, Med Biotechnol Dept, Tehran, Iran
关键词
Cancer stem cell; Ovarian cancer; Isolation; Detection; Drug resistance; BCL-X-L; EPITHELIAL OVARIAN; SELF-RENEWAL; HEDGEHOG PATHWAY; IN-VITRO; INTRAEPITHELIAL CARCINOMA; SIGNALING PATHWAY; INITIATING CELLS; SEROUS CARCINOMA; SIDE-POPULATION;
D O I
10.1186/s13048-019-0588-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Ovarian cancer has the highest ratio of mortality among gynecologic malignancies. Chemotherapy is one of the most common treatment options for ovarian cancer. However, tumor relapse in patients with advanced tumor stage is still a therapeutic challenge for its clinical management. Main body Therefore, it is required to clarify the molecular biology and mechanisms which are involved in chemo resistance to improve the survival rate of ovarian cancer patients. Cancer stem cells (CSCs) are a sub population of tumor cells which are related to drug resistance and tumor relapse. Conclusion In the present review, we summarized the recent findings about the role of CSCs in tumor relapse and drug resistance among ovarian cancer patients. Moreover, we focused on the targeted and combinational therapeutic methods against the ovarian CSCs.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Ovarian cancer stem cells and targeted therapy
    Vahideh Keyvani
    Moein Farshchian
    Seyed-Alireza Esmaeili
    Hadi Yari
    Meysam Moghbeli
    Seyed-Reza Kazemi Nezhad
    Mohammad Reza Abbaszadegan
    [J]. Journal of Ovarian Research, 12
  • [2] Targeted therapy against cancer stem cells
    Yang, Tao
    Rycaj, Kiera
    [J]. ONCOLOGY LETTERS, 2015, 10 (01) : 27 - 33
  • [3] Biomarkers and targeted therapy for cancer stem cells
    Liu, Yusheng
    Wang, Hua
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (01) : 56 - 66
  • [4] Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
    Cao, Pengpeng
    Tirughana, Revathiswari
    Nwokafor, Ugochi
    Aramburo, Soraya
    Flores, Linda
    Berlin, Jacob
    Aboody, Karen S.
    [J]. MOLECULAR THERAPY, 2016, 24 : S81 - S82
  • [5] Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy
    Leao, Ricardo
    Domingos, Celia
    Figueiredo, Arnaldo
    Hamilton, Robert
    Tabori, Uri
    Castelo-Branco, Pedro
    [J]. UROLOGIA INTERNATIONALIS, 2017, 99 (02) : 125 - 136
  • [6] Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy
    Kaur, Jasmeet
    Bhattacharyya, Shalmoli
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] At the crossroads of cancer stem cells and targeted therapy resistance
    Wang, Anbang
    Qu, Le
    Wang, Linhui
    [J]. CANCER LETTERS, 2017, 385 : 87 - 96
  • [8] Targeted therapy of cancer stem cells: science or fiction
    Ogris, Manfred
    Roidl, Andreas
    [J]. THERAPEUTIC DELIVERY, 2013, 4 (02) : 135 - 138
  • [9] Colon Cancer Stem Cells: Promise of Targeted Therapy
    Todaro, Matilde
    Francipane, Maria Giovanna
    Medema, Jan Paul
    Stassi, Giorgio
    [J]. GASTROENTEROLOGY, 2010, 138 (06) : 2151 - 2162
  • [10] Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
    Zhan, Qinglei
    Wang, Chunmei
    Saiming Ngai
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013